Advertisement
Canada Markets closed
  • S&P/TSX

    24,822.54
    +132.06 (+0.53%)
     
  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     
  • DOW

    43,275.91
    +36.86 (+0.09%)
     
  • CAD/USD

    0.7246
    -0.0004 (-0.0515%)
     
  • CRUDE OIL

    69.34
    -1.33 (-1.88%)
     
  • BTC-CAD

    94,463.86
    +231.16 (+0.25%)
     
  • CMC Crypto 200

    1,308.28
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,736.40
    +28.90 (+1.07%)
     
  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ

    18,489.55
    +115.94 (+0.63%)
     
  • VOLATILITY

    18.03
    -1.08 (-5.65%)
     
  • FTSE

    8,358.25
    -26.88 (-0.32%)
     
  • NIKKEI 225

    38,981.75
    +70.56 (+0.18%)
     
  • CAD/EUR

    0.6666
    -0.0024 (-0.36%)
     

Invest $7,000 in This Dividend Stock for Immense Passive Income

telehealth stocks
Image source: Getty Images

Written by Amy Legate-Wolfe at The Motley Fool Canada

When it comes to dividend stocks, monthly income can be a top way to earn income even if the market is volatile. If you’re looking for a reliable dividend stock to add to your portfolio for long-term monthly passive income, Extendicare (TSX:EXE) is one to seriously consider. With a solid history in the healthcare industry, particularly in senior care, Extendicare offers both stability and consistent payouts. This reliability makes it a standout choice for passive income investors.

Into earnings

The dividend stock’s recent earnings report for Q2 2024 highlighted robust performance, with revenue growing by 13.3% year over year. Net income also skyrocketed by an impressive 1,227%, thus signalling management’s success in navigating a post-pandemic recovery while maintaining strong cost control measures. Return on equity sits at a stunning 60%, indicating the company’s ability to turn investments into profits efficiently. This is a great sign for long-term investors.

However, the stock is down from its 52-week highs, with a 200-day moving average of $7.69. While this may seem concerning at first, it’s important to recognize that much of the decline can be attributed to broader market volatility, especially in healthcare sectors impacted by inflation and rising labour costs. Management has been proactive, focusing on increasing efficiency and exploring new growth areas like home health care, which should mitigate the risks over time.

One of Extendicare’s key strategies has been a shift toward expanding its home healthcare services. This is becoming increasingly popular as more seniors prefer aging at home. The focus not only taps into a growing market but also positions the company for continued revenue growth. This pivot also reduces the company’s reliance on traditional long-term care facilities, which have seen more challenges post-pandemic.

What you get now

Looking ahead, the dividend stock is expected to maintain its consistent dividend payouts. All thanks to a stable revenue stream and a commitment to returning value to shareholders. Management continues to invest in technology and expand services. So there’s potential for revenue to keep growing at a healthy pace. These moves suggest that Extendicare is building a resilient business model that can weather short-term headwinds.

Meanwhile, the dividend stock has been delivering monthly dividends at an annual rate of $0.48, yielding around 5.14%. This makes it appealing for those looking to maximize cash flow without waiting for quarterly payouts. The dividend stock’s long-standing business in senior living and home healthcare services has been bolstered by a growing demand for these services, especially with Canada’s aging population, setting up a promising future for the stock.

For investors seeking a steady income stream with a focus on the long term, Extendicare offers the best of both worlds. Its current dividend yield is attractive, and its proactive approach to growth and efficiency puts it in a strong position for the future. While it’s not without risks, such as labour cost pressures, the dividend stock’s strong financials and management strategy provide confidence.

Bottom line

All considered, Extendicare is a top pick for those seeking monthly passive income from dividends. Its attractive yield, coupled with sound management and a promising future, make it a standout option in the healthcare sector. In fact, $7,000 could create immense passive income from dividends and should shares climb back to all-time highs.

COMPANY

RECENT PRICE

NUMBER OF SHARES

DIVIDEND

TOTAL PAYOUT

FREQUENCY

INVESTMENT

EXE – now

$9.35

749

$0.48

$359.52

monthly

$7,000

EXE – highs

$10.35

749

$0.48

$359.52

monthly

$7,752.15

Now you have $359.52 in dividends and $752.15 in returns for $1,111.67 in passive income! With the company’s commitment to growth and efficiency, this stock could offer both reliable income and potential capital appreciation for long-term investors.

The post Invest $7,000 in This Dividend Stock for Immense Passive Income appeared first on The Motley Fool Canada.

Should you invest $1,000 in Extendicare right now?

Before you buy stock in Extendicare, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Extendicare wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,380.01!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 32 percentage points since 2013*.

See the 10 stocks * Returns as of 10/14/24

More reading

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

2024